Chemotherapy with cetuximab in head and neck squamous cell carcinoma: immunological aspects and markers of treatment effectiveness in clinical practice

Chemotherapy with cetuximab in head and neck squamous cell carcinoma: immunological aspects and markers of treatment effectiveness in clinical practice

Introduction. Chemotherapy in combination with targeted therapy (CT + TT) using a monoclonal antibody against epidermal growth factor receptor (EGFR) cetuximab and subsequent maintenance targeted therapy (CT + TT/TT) is the leading 1st line therapy of recurrent/metastatic head and neck squamous cell...

Full description

Saved in:
Bibliographic Details
Main Authors: A. I. Stukan, S. I. Kutukova, E. A. Nefedova, V. A. Porkhanov, V. N. Bodnya, T. Yu. Semiglazova, N. A. Tsygan, V. V. Kudrina, I. I. Aseeva, Yu. Yu. Stefanova, A. A. Kurmanaliev, M. A. Chagiev
Format: Article
Language:Russian
Published: ABV-press 2024-06-01
Series:Опухоли головы и шеи
Subjects:
chemotherapy
targeted therapy
cetuximab
systemic inflammation
head and neck squamous cell carcinoma
Online Access:https://ogsh.abvpress.ru/jour/article/view/965
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://ogsh.abvpress.ru/jour/article/view/965

Similar Items